CVS Health Corp (NYSE:CVS)’s traded shares stood at 12.41 million during the last session, with the company’s beta value hitting 0.59. At the close of trading, the stock’s price was $58.75, to imply a decrease of -5.01% or -$3.1 in intraday trading. The CVS share’s 52-week high remains $72.51, putting it -23.42% down since that peak but still an impressive 25.86% since price per share fell to its 52-week low of $43.56. The company has a valuation of $74.32B, with an average of 7.32 million shares in intraday trading volume over the past 10 days and average of 8.30 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for CVS Health Corp (CVS), translating to a mean rating of 1.67. Of 20 analyst(s) looking at the stock, 0 analyst(s) give CVS a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 14 recommend it as a Buy.
CVS Health Corp (NYSE:CVS) trade information
After registering a -5.01% downside in the last session, CVS Health Corp (CVS) has traded red over the past five days. The 5-day price performance for the stock is -7.19%, and -13.07% over 30 days. With these gigs, the year-to-date price performance is 0.72%. Short interest in CVS Health Corp (NYSE:CVS) saw shorts transact 16.02 million shares and set a 2.27 days time to cover.
The extremes give us $77 and $79 for target low and target high price respectively. As such, CVS has been trading -34.47% off suggested target high and -31.06% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -6.37% for the past 5-year period. While 2025 is set for a 12.99% return in earnings, projections for the next 5 years are at 14.08% annually.
CVS Dividends
CVS Health Corp has its next earnings report out on 2025-May-01. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. CVS Health Corp has a forward dividend ratio of 2.66, with the share yield ticking at 4.53% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 3.13%.
CVS Health Corp (NYSE:CVS)’s Major holders
CVS Health Corp insiders hold 1.08% of total outstanding shares, with institutional holders owning 87.50% of the shares at 88.46% float percentage. In total, 87.50% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 116.35 million shares (or 9.2635% of shares), all amounting to roughly $6.87 billion.
The next major institution holding the largest number of shares is BLACKROCK INC. with 100.15 million shares, or about 7.9738% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $5.91 billion.
We also have Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the CVS Health Corp (CVS) shares. Going by data provided on Mar 31, 2025 , Dodge & Cox Funds-Dodge & Cox Stock Fund holds roughly 48.22 shares. This is just over 3.81% of the total shares, with a market valuation of $2.83 billion. Data from the same date shows that the other fund manager holds a little less at 39.83, or 3.15% of the shares, all valued at about 2.34 billion.
